Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia

Clinical Neuropharmacology

Volumn 29, Issue 1, 2006, Pages 52-56

  Havaki Kontaxaki, Beata J ^a   Ferentinos, Panayotis P ^a   Kontaxakis, Vassilis P ^a   Paplos, Konstantinos G ^a   Soldatos, Constantin R ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Clozapine; Concurrent; ECT; Resistant; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PIPAMPERONE; PSYCHOTROPIC AGENT; RISPERIDONE; VALPROIC ACID; ZUCLOPENTHIXOL DECANOATE;

CLINICAL TRIAL; CONFUSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; ELECTRODE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOTENSION; MEDICAL ASSESSMENT; MEDLINE; MEMORY DISORDER; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME; DRUG RESISTANCE;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; HUMANS; RECURRENCE; SCHIZOPHRENIA;

EID: 33646354639     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200601000-00012     Document Type: Review

References (41)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
2. Meltzer HY, Bastani B, Kwon KY, et al. A prospective study of clozapine in treatment-resistant patients: I. Preliminary report. Psychopharmacology. 1989;99(suppl):S68-S72.
3. Chong SA, Remington G. Clozapine augmentation: safety and efficacy. Schizophr Bull. 2000;26:421-440.
4. Buckley P, Miller A, Olsen J, et al. When symptoms persist: clozapine augmentation strategies. Schizophr Bull. 2001;27:615-628.
5. Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, et al. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients. Clin Neuropharmacol. 2005;28:50-53.
6. Taylor P, Fleminger JJ. ECT for schizophrenia. Lancet. 1980;1:1380-1382.
7. Brandon S, Gabriel AR, Impastato DJ. Leicester ECT trial: results in schizophrenia. Br J Psychiatry. 1985;146:177-183.
8. Abraham KR, Kulhara P. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br J Psychiatry. 1987;151:152-155.
9. Friedel RO. The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull. 1986;22:928-930.
10. Gujavarty K, Greenberg LB, Fink M. Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive-symptom psychosis. Convuls Ther. 1987;3:185-195.
11. Sajatovic M, Meltzer HY. The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. Convuls Ther. 1993;9:167-175.
12. Chanpattana W, Chakrabhand ML, Kongsakon R, et al. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J ECT. 1999;15:129-139.
13. Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:373-379.
14. Fink M. Clozapine and electroconvulsive therapy. Arch Gen Psychiatry. 1990;47:290-291.
15. Klapheke MM. Clozapine ECT, and Schizoaffective disorder, bipolar type. Convuls Ther. 1991;7:36-39.
16. Klapheke MM. Follow-up on clozapine and ECT. Convuls Ther. 1991;7:303-305.
17. Masiar SJ, Johns CA. ECT following clozapine. Br J Psychiatry. 1991;158:135-136.
18. Bloch Y, Pollack M, Mor I. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry. 1996;169:253-254.
19. Beale MD, Pritchett JT, Kellner CH. Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine. Convuls Ther. 1994;10:228-231.
20. Green AI, Zalma A, Berman I, et al. Clozapine following ECT: a two-step treatment. J Clin Psychiatry. 1994;55:388-390.
21. Lurie SN. Combined use of ECT and clozapine. J Clin Psychiatry. 1996;57:94-95.
22. James DV, Gray NS. Elective combined electroconvulsive and clozapine therapy. Int Clin Psychopharmacol. 1999;14:69-72.
23. Safferman AZ, Munne R. Combining clozapine with ECT. Convuls Ther. 1992;8:141-143.
24. Factor SA, Molho ES, Brown DL. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995;7:304-307.
25. Poyurovsky M, Weizman A. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania. Eur Psychiatry. 1996;11:319-321.
26. Benatov R, Sirota P, Megged S. Neuroleptic-resistant schizophrenia treated with clozapine and ECT. Convuls Ther. 1996;12:117-121.
27. Bhatia SC, Bhatia SK, Gupta S. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. J ECT. 1998;14:280-283.
28. Husni M, Haggarty J, Peat C. Clozapine does not increase ECT-seizure duration. Can J Psychiatry. 1999;44:190-191.
29. Kales HC, Dequardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:547-556.
30. Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT. 2000;16:204-207.
31. Kho KH, Blansjaar BA, De Vries S, et al. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia. An open label study. Eur Arch Psychiatry Clin Neurosci. 2004;254:372-379.
32. Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsive- clozapine therapy. Clin Neuropharmacol. 2000;23:14-16.
33. Landy DA. Combined use of clozapine and electroconvulsive therapy. Convuls Ther. 1991;7:218-221.
34. Cardwell BA, Nakai B. Seizure activity in combined clozapine and ECT: a retrospective view. Convuls Ther. 1995;11:110-113.
35. Frankenburg FR, Suppes T, Mclean PE. Combined clozapine and electroconvulsive therapy. Convuls Ther. 1993;9:176-180.
36. Fink M. ECT and clozapine in schizophrenia. J ECT. 1998;14:223-226.
37. Breier A, Buchanan RW, Irish D, et al. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp Community Psychiatry. 1993;44:1145-1149.
38. Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry. 2001;50:898-911.
39. Perry PJ, Miller DD, Arndt SV, et al. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry. 1991;148:231-235.
40. Llorca PM, Lancon C, Disdier B, et al. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. J Psychiatry Neurosci. 2002;27:30-37.
41. Mauri MC, Volonteri LS, Dell'osso B, et al. Predictors of clinical outcome in schizophrenic patients responding to clozapine. J Clin Psychopharmacol. 2003;23:660-664.